ISRG Q4 2025

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Earnings

Intuitive Surgical capped a landmark year with a standout fourth quarter, posting non-GAAP EPS of $2.53 against a consensus estimate of $2.26, a beat of nearly 12%, while revenue of $2.87 billion topped expectations by 4.14% and climbed 18.8% year-ov… Read more Intuitive Surgical capped a landmark year with a standout fourth quarter, posting non-GAAP EPS of $2.53 against a consensus estimate of $2.26, a beat of nearly 12%, while revenue of $2.87 billion topped expectations by 4.14% and climbed 18.8% year-over-year. The primary engine behind the quarter was accelerating adoption of the da Vinci 5 surgical system, with 303 placements of the next-generation platform during the period compared to just 174 a year earlier, helping drive worldwide procedure volumes roughly 18% higher and pushing instruments and accessories revenue, the company's highest-margin recurring stream, up 17% to $1.66 billion. The results also carried the full-year top line past $10 billion for the first time, with 2025 revenue reaching $10.06 billion and non-GAAP EPS finishing at $8.93. Looking ahead, management guided for 2026 da Vinci procedure growth of 13% to 15%, a modest deceleration from 2025's pace, and flagged tariff exposure as a meaningful risk given manufacturing concentrated in Mexico and Germany, estimating roughly 1.2% of revenue in tariff headwinds within its 67% to 68% non-GAAP gross margin outlook.